Abstract
Thrombospondins (TSPs) are secreted glycoproteins that play key roles in interactions between cells and the extracellular matrix. Here, we describe the 2.6 Å resolution crystal structure of the glycosylated signature domain of human TSP-2, which includes three epidermal growth factor-like (EGF-like) modules, 13 aspartate-rich repeats, and a lectin-like module. These elements interact extensively to form three striking structural regions termed the stalk, wire, and globe. The TSP-2 signature domain is stabilized by these interactions and by a network of 30 bound Ca2+ ions and 18 disulfide bonds. The structure suggests how genetic alterations of TSPs result in disease.
Keywords: calcium binding, extracellular matrix, lectin-like module, skeletal dysplasia, epidermal growth factor-like module, protein crystallography
Thrombospondins (TSPs) are a family of five secreted multimodular metallo/glycoproteins that have diverse roles involving interactions between cells and the extracellular matrix{Adams, 2004 #3568}. For TSP-2, these functions are critical for such processes as synaptogenesis{Christopherson, 2005 #3578}, megakaryocytopoiesis{Kyriakides, 2003 #3576}, and the foreign body reaction{Kyriakides, 2001 #3588}. All TSPs contain a highly conserved “signature domain” consisting of tandem epidermal growth factor-like (EGF-like) modules, aspartate-rich repeats, and a lectin-like module at their C-termini ( Fig. 1a). These modules are conserved with remarkable fidelity as is evidenced by a 458-residue stretch of fly TSP and human TSP-2 in the signature domain that are 60% identical without an insertion or deletion{Adams, 2003 #3571;LaBell, 1993 #340}. The signature domain contains the sites of polymorphisms and mutations linked to familial coronary artery disease and two skeletal disorders, pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (EDM1){Topol, 2001 #3537;Kennedy, 2005 #3585;Posey, 2004 #3579}.
Figure 1.

Structure of human TSP-2. (a) Schematic diagram of TSP-2. Each TSP-2 monomer is composed of a N-terminal module (N), an oligomerization domain (O), a procollagen module (C), and type-1 or properdin modules (P123) followed by the signature domain common to all TSPs. In human TSP-2, this domain consists of tandem EGF-like modules (EGF1 (residues 551–589, yellow), EGF2 (590–647, orange), and EGF3 (648–692, wheat)), aspartate-rich repeats (693–956, blue), and a lectin-like module (957–1172, magenta). Glycosylation sites are shown as green ovals. The arrowhead above the EGF-like repeats indicates the site of extra EGF-like module in TSP-3, -4 and -5. (b) Stereo diagram of the glycosylated residue Asn1069. The 2Fo-Fc electron-density map for the region is shown contoured at 1.3 σ (c) Four views of the ribbon diagram (top) and corresponding surface representation (bottom) of the crystal structure of the signature domain of human TSP-2. Modules are colored as in Fig. 1a, with Ca2+ ions (red), carbohydrates (green), and disulfide bonds (stick representation) shown.
Here, we describe the 2.6 Å resolution crystal structure of the complete glycosylated signature domain of human TSP-2, which includes three epidermal growth factor-like (EGF-like) modules, 13 aspartate-rich repeats, and a lectin-like module, along with 30 bound Ca2+ ions. The structure reveals the highly intertwined nature of the signature domain that includes major interactions among the different parts of the molecule. The structure furthermore establishes a molecular explanation of how known genetic alterations of TSPs result in disease.
Results
Structure of the human TSP-2 signature domain
The crystal structure of the signature domain of human TSP-2 was solved using a combination of anomalous scattering and molecular replacement approaches. Electron-density maps, particularly those derived from molecular replacement using the structure of a fragment of the signature domain from TSP-1{Kvansakul, 2004 #3561}, were of high quality ( Fig. 1b), and allowed modelling of the entire domain structure.
The overall structure of the TSP-2 signature domain can be visually divided into three major features: the stalk, wire, and globe (Fig. 1c and Supplementary Fig. 1 online). The stalk comprises the two N-terminal EGF-like modules (EGF1 and EGF2) and extends 60 Å from the base of the molecule. The wire, with a contour length of ~170 Å, is formed by the repetitive aspartate-rich sequences draped around 26 Ca2+ ions. The third EGF-like module (EGF3) serves as a clasp to close the tortuous circle formed by the wire. The globe consists of the lectin-like module suspended beneath the wire and EGF3. This arrangement creates a prominent opening with dimensions of 14 Å x 40 Å between the wire and the globe.
Supplementary Figure 1.

Stereo ribbon diagram of the crystal structure of the signature domain of human TSP-2. Structure is color-coded to indicate the positions of the tandem EGF-like modules (EGF1 (residues 551–589, yellow), EGF2 (590–647, orange), and EGF3 (648–692, wheat)), aspartate-rich repeats (693–956, blue), and a lectin-like module (957–1171, magenta). Ca2+ ions (red), carbohydrates (green), and disulfide bonds (stick representation) are shown.
Stalk, wire, and globe elements of the signature domain
The EGF-like modules in the stalk are characterized by unusual cysteine spacing and by binding a Ca2+ ion at their interface. Each module has the Cys1-Cys3, Cys2-Cys4, Cys5-Cys6 disulfide connectivity typical of the cEGF subtype 1 grouping{Wouters, 2005 #3583}. However, two residues separate the 4th and 5th cysteines in both, whereas a single residue separates the cysteines in other EGF-like modules in this grouping (Supplementary Fig. 2 online). This unusual spacing extends the axial lengths of EGF1 and EGF2 to 29.0 Å and 32.5 Å, respectively, and could prove important for forming distinctive interaction sites on their surfaces ( Fig. 1c). In addition, EGF2 forms a class-A Ca2+-binding EGF-like module{Boswell, 2004 #3575} and binds a single Ca2+ ion (Fig. 2a and Supplementary Table 1 online). The Ca2+ ion is bound at the interface between the EGF-like modules in the stalk and likely stabilizes their co-axial alignment as noted in other tandem Ca2+-binding EGF-like modules{Boswell, 2004 #3575}.
Supplementary Figure 2.

Sequence and secondary structure of the signature domain of human TSP-2. Helices (boxes) and β-strands (arrows) are numbered sequentially above the sequence and are color-coded as in Fig. 1. Cysteines connected by lines form disulfide bonds in the structure. Residues colored green are glycosylated. Underlined or bold-face residues are sites that are mutated or deleted, respectively, in either EDM-1 or PSACH. Two insertion mutations map to the position labeled with a “Y”.
Figure 2.

Ca2+ coordination in the stalk and wire elements of TSP-2. (a) Ca2+ coordination at the interface between EGF1 and EGF2, colored as in Figure 1. Ca2+-coordinating residues are shown and labeled. Reside labelled with (mc) ligand via their main chain carbonyl groups. (b) Overlay of the five N-type Ca2+-binding motifs. Ca2+-binding residues are labeled. “Xxx” represents any residue. Ca2+ ions are shown as red spheres. Residues labeled “(mc)” coordinate Ca2+ via main chain carbonyl groups. (c) Overlay of the eight C-type Ca2+-binding motifs. The insert sequence from repeat 1C has been removed for the alignment. (d) The glycosylated insertion element in repeat 1C and coordination of an additional Ca2+ between repeats 2N and 3C are highlighted by showing 1C, 2N, 3C, and 4C in stereo. (e) Alignment of Ca2+-binding repeats in the wire. The Ca2+ coordination scheme for each residue is colored-coded as follows: side chain binding to two Ca2+ ions (red), side chain binding to one Ca2+ ion (purple), main chain carbonyl binding to one Ca2+ ion (green or underlined), and water-mediated binding (blue or italicized). Disulfide bonds are shown in red lines. The symbols + or - indicate N-type repeats that bind three or one Ca2+, respectively, rather than two. The arrowhead above repeat 1C indicates the site of the 13-residue insertion, which is shown. The arrowhead above repeat 11C indicates the location of the 4-residue insertion that is present in TSP-3 and -4. Residue numbers are listed to the left of the sequence and coordination numbering is shown above.
Supplementary Table 1. TSP-2 coordination of the 30 bound Ca2+.
The coordination scheme for each of the 30 Ca2+ ions is colored-coded as follows: side chain binding to two Ca2+ ions (red box, labeled “bidentate”), side chain binding to one Ca2+ ion (purple, labeled “side chain”), main chain carbonyl binding to one Ca2+ ion (green, labeled “main chain”), water-mediated binding (blue, labeled “via water”), and water or unidentified liganding element (white, labeled “WATER” or “NO DENSITY”). The structural element within TSP-2 that is responsible for binding in indicated in the right-most column.
| EGF-2 | |||||||
| Ca1 | D590 side chain | L591 main chain | E593 side chain | N612 side chain | T613 main chain | G616 main chain | EGF-2 |
| Wire | |||||||
| Ca2 | D694 side chain | D696 bidentate | D698 bidentate | W700 main chain | N702 via water | D718 bidentate | Wire 1C |
| Ca3 | D696 bidentate | D698 bidentate | D718 bidentate | C720 main chain | L723 main chain | N725 side chain | Wire 1C |
| Ca4 | D730 side chain | D732 bidentate | D734 bidentate | I736 main chain | D738 via water | D741 bidentate | Wire 2N |
| Ca5 | D732 bidentate | D734 bidentate | D741 bidentate | D743 main chain | NO DENSITY | N746 side chain | Wire 2N and 3C |
| Ca6 | D738 main chain | D741 main chain | D744 side chain | WATER | WATER | D751 side chain | Wire 2N and 3C |
| Ca7 | D743 side chain | D745 bidentate | D747 bidentate | V749 main chain | NO DENSITY | D754 bidentate | Wire 3C |
| Ca8 | D745 bidentate | D747 bidentate | D754 bidentate | C756 main chain | L759 main chain | N761 side chain | Wire 3C |
| Ca9 | D766 side chain | D768 bidentate | D770 bidentate | V772 main chain | D777 bidentate | N784 via water | Wire 4C |
| Ca10 | D768 bidentate | D770 bidentate | D777 bidentate | C779 main chain | V782 main chain | N784 side chain | Wire 4C |
| Ca11 | D789 side chain | D791 side chain | N793 via water | E795 main chain | D797 via water | WATER | Wire 5N |
| Ca12 | D802 side chain | D804 bidentate | D806 bidentate | V808 main chain | N810 via water | D813 bidentate | Wire 6C |
| Ca13 | D804 bidentate | D806 bidentate | D813 bidentate | C815 main chain | V818 main chain | N820 side chain | Wire 6C |
| Ca14 | D825 side chain | D827 bidentate | D829 bidentate | V831 main chain | D833 via water | D836 bidentate | Wire 7C |
| Ca15 | D827 bidentate | D829 bidentate | D836 bidentate | C838 main chain | V841 main chain | N843 side chain | Wire 7C |
| Ca16 | D848 side chain | D850 bidentate | D852 bidentate | V854 main chain | D856 via water | D859 bidentate | Wire 8N |
| Ca17 | D850 bidentate | D852 bidentate | D859 bidentate | N861 side chain | Q870 via water | NO DENSITY | Wire 8N and 9C |
| Ca18 | D863 side chain | D865 bidentate | D867 bidentate | H869 main chain | N871 via water | D874 bidentate | Wire 9C |
| Ca19 | D865 bidentate | D867 bidentate | D874 bidentate | C876 main chain | I879 main chain | N881 side chain | Wire 9C |
| Ca20 | D886 side chain | D888 bidentate | D890 bidentate | Q892 main chain | NO DENSITY | D897 bidentate | Wire 10N |
| Ca21 | D888 bidentate | D890 bidentate | D897 bidentate | D899 main chain | WATER | N902 side chain | Wire 10N and 11C |
| Ca22 | D894 main chain | D897 main chain | D900 side chain | WATER | WATER | D907 side chain | Wire 10N and 11C |
| Ca23 | D899 side chain | D901 bidentate | D903 bidentate | V905 main chain | D907 via water | D910 bidentate | Wire 11C |
| Ca24 | D901 bidentate | D903 bidentate | D910 bidentate | C912 main chain | V915 main chain | N917 side chain | Wire 11C |
| Ca25 | D922 side chain | D924 side chain | D926 side chain | R928 main chain | WATER | D930 side chain | Wire 12N |
| Ca26 | D935 side chain | D937 bidentate | D939 bidentate | I941 main chain | D943 via water | D946 bidentate | Wire 13C |
| Ca27 | D937 bidentate | D939 bidentate | D946 bidentate | C948 main chain | N951 main chain | I954 main chain | Wire 13C |
| Lectin | |||||||
| Ca28 | D1019 main chain | D1021 main chain | Q1044 side chain | D1106 side chain | WATER | WATER | Lectin Single |
| Ca29 | D1021 bidentate | D1022 side chain | D1023 bidentate | Q1047 side chain | WATER | WATER | Lectin Double |
| Ca30 | N993 side chain | D1021 bidentate | D1023 bidentate | S1156 side chain | S1156 main chain | WATER | Lectin Double |
The wire element comprises 13 aspartate-rich repeats that form individual globular folds connected in a disulfide bond-stabilized “beads on a string” arrangement ( Fig. 1c). Each repeat envelops a Ca2+ core and can be classified into one of two classes, N-type and C-type, based on its sequence{Kvansakul, 2004 #3561}. N-type repeats are 13- or 15- residues in length and their tertiary structures superimpose with a root mean square deviation (rmsd) of ~0.35 Å for all Cα atoms ( Fig. 2b). C-type repeats are 23 residues long and superimpose with a rmsd of ~0.36 Å ( Fig. 2c). Each repeat binds two Ca2+ ions except 5N and 12N, which bind only one (Supplementary Table 1 online). In addition, single Ca2+ ions are bound at the interfaces of 2N and 3C and of 10N and 11C ( Fig. 2d). The individual Ca2+-binding repeats are linked via disulfide bonds to each other in an arrangement that resembles struts along the wire axis, likely enhancing the overall rigidity of the wire element. Interestingly, the circular dichroic spectrum of a TSP-2 construct comprising solely its aspartate-rich repeats displays a Ca2+-dependent ellipticity minimum at 203 nm that is characteristic of the circular dichroic spectra of all TSPs studied to date{Misenheimer, 2003 #3556}. The repeat-containing protein is denatured only slightly more readily than the full signature domain{Misenheimer, 2003 #3556}. Thus, the wire element forms a stable Ca2+-dependent structure that is independent of the rest of the signature domain. Independent folding by the wire, coupled with the observations that the lectin-like domains of TSP-1{Kvansakul, 2004 #3561} and TSP-2{Misenheimer, 2001 #3406} are not soluble when expressed in isolation, implies that the wire may act as a scaffold in formation of the overall signature domain fold.
The globe lectin-like module is composed largely of β-sheets in a jelly-roll packing arrangement that is nearly identical in structure to the analogous fold from TSP-1{Kvansakul, 2004 #3561}. Differences between the TSP-1 and TSP-2 structures of this module include the carbohydrate attached at Asn1069 in TSP-2 and the presence of three bound Ca2+ ions in the TSP-2 globe compared to four in TSP-1 (Fig. 1b,c and Supplementary Fig. 3 online). The residues that coordinate a fourth Ca2+ ion in the TSP-1 structure are present in TSP-2 but are part of a meandering loop in contrast to the tight circular loop observed in TSP-1.
Supplementary Figure 3.

Comparison of the crystal structures of the TSP-2 signature domain (A) and the TSP-1 signature domain fragment1 (B). Both structures are colored and shown in the same orientations as for the TSP-2 signature domain in Figure 1 (main text).
Extensive interactions occur among the components of the signature domain in the Ca2+-replete signature domain structure ( Fig. 1c). The third EGF-like module functions a major organizer of the signature domain through its interactions with the wire element (repeats 1C, 12N, and 13C), the second EGF-like module, and the globe element. The lectin-like and second EGF-like modules make additional direct contacts with the wire element. The discovery of these interaction sites helps to explain the structural basis of disease-linked TSP mutations (see below).
Discussion
Role of Ca2+ in the TSP signature domain
The large amount of Ca2+ bound by the TSP-2 signature domain is consistent with the documented sensitivity of TSP structures to changes in Ca2+ concentration. Rotary shadowing electron microscopy experiments with TSP-1 and -2 demonstrate gross Ca2+-dependent dynamics within the signature domain{Lawler, 1982 #350;Lawler, 1985 #245;Chen, 1996 #1457}. Comparing the present structure and the rotary shadowing images, it appears that upon removal of Ca2+, EGF3 and part of the wire dissociate from the globe module, forming an extended structure along with more N-terminal components. Solution spectroscopic experiments further demonstrate that there are dramatic Ca2+-dependent changes in the TSP signature domain structure{Misenheimer, 2003 #3556}. In the Ca2+-replete signature domain structure presented here, both the αvβ3 integrin-{Lawler, 1989 #329;Chen, 1994 #595} and CD47-binding sites{Gao, 1994 #927} are buried and inaccessible. However, removal of Ca2+ could alter TSP conformation to expose these sites, making them available for binding and thereby modulating the activity of TSP, as proposed earlier{Kvansakul, 2004 #3561}. The Ca2+-dependent conformational changes seen in the TSP signature domain structure suggest that TSPs may act as buffers as well as sensors of Ca2+ concentration in solution.
Implications of structural differences among TSPs
Two deviations from the canonical 23-residue C-type Ca2+-binding repeat are tolerated by TSPs. First, repeat 1C of human TSP-2 contains a 13-residue insert between positions 10 and 11 ( Fig. 2d,e). Despite this insertion, the residues of the interrupted halves of repeat 1C are positioned identically to C-type repeats without the insert ( Fig. 2c). The insert forms a structured loop that is stabilized by a disulfide bond and interacts extensively with EGF3. An N-glycosylation recognition sequence is present at the apex of the inserted loop, and the proximal three saccharides are resolved in the structure ( Fig. 1c, 2d). A similar insertion is present in the TSP-1 sequence, whereas in TSP-3, -4, and -5, the inserts lack the glycosylation sequence and are only 10 residues long. The second tolerated variation is an insertion of four residues between positions 10 and 11 of repeat 11C in TSP-3 and -4. From the structure presented here, it seems unlikely that an insertion this short could be accommodated without considerable disturbance of the 11C structure. This insert could distort the tertiary structure of the wire, making the structure of TSP-3 and -4 different from TSP-2. The importance of these variations is not clear but they could impart specialized functions upon the different TSP family members.
Structural interpretation of signature domain disease-linked mutations
Although a partial structure of the signature domain of TSP-1 has previously been solved{Kvansakul, 2004 #3561}, it lacks the three EGF-like modules, the seven N-terminal repeats of the wire (and the coordinated Ca2+ ions) and the four glycosylation sites of the signature domain (Supplementary Fig. 3 online). Importantly, because the TSP-1 structure is not the complete structure of the signature domain, it lacks the extensive interaction sites found in the TSP-2 structure. The importance of these interactions is evidenced by the identification of disease-linked genetic alterations at these sites in TSP-1, -4 and -5 (Fig. 3 and Supplementary Table 2 online). A polymorphic residue in TSP-1 (N700S) associated with premature coronary artery disease{Topol, 2001 #3537} maps to wire repeat 1C near the interaction site between EGF3, the wire and the globe. The homologous residue in TSP-2, Asn702, coordinates Ca2+ through a water ( Fig. 2c,e), a finding consistent with the decrement in Ca2+-binding associated with the Ser700 allele{Hannah, 2004 #3574}. A polymorphism in TSP-4 (A374P), also associated with premature coronary artery disease{Topol, 2001 #3537}, is in an extra EGF-like module that is most similar to EGF2 of TSP-2. The extra EGF-like module is in a position that would require it to subserve the role of EGF2 in the signature domain and interact with the wire, which could be altered in the TSP-4 variant.
Supplementary Table 2. Disease-linked TSP-family mutations.
List of currently known mutations within TSP-5 signature domain that are linked to PSACH or EDM-1 and their apparent roles derived from the presented crystal structure of TSP-2. Mutations are divided into “Missense” and “Deletion or Insertion” mutations in the first and second groupings. Mutations are listed with TSP-5 numbering, followed by the associated disease, the analogous residue(s) in the TSP-2 signature domain, the roles played by the residue(s) in the TSP-2 signature domain structure, and the predicted role in TSP-5.
| Missense Mutations | ||||
|---|---|---|---|---|
| TSP-5 Mutation | Disease | Equivalent TSP-2 residue | Deduced Role in TSP-2 | Predicted Role in TSP-5 |
| Wire | ||||
| D271H | PSACH | D696 | Ca 2 and 3 coordination | Ca 2 and 3 coordination |
| L272P | PSACH | L697 | interaction with lectin | interaction with lectin |
| P276R | EDM1 | P701 | ? | |
| D290N | PSACH | D718 | Ca 2 and 3 coordination | Ca 2 and 3 coordination |
| C292W | PSACH | C720 | Ca 3 coordination and disulfide bond | Ca 3 coordination |
| S298L | PSACH | S726 | interaction with lectin | interaction with lectin |
| G299R | PSACH | G727 | interaction with lectin | interaction with lectin |
| D302V | EDM1 | D730 | Ca 4 coordination | Ca 4 coordination |
| G309R | PSACH | G737 | ? | |
| D310V | EDM1 | D738 | Ca 4 and 6 coordination | Ca 4 and 6 coordination |
| C328R | PSACH | C756 | Ca 8 coordination and disulfide bond | Ca 8 coordination |
| D342Y | EDM1 | D770 | Ca 9 and 10 coordination | Ca 9 and 10 coordination |
| D349G/V | PSACH | D777 | Ca 9 and 10 coordination | Ca 9 and 10 coordination |
| C351Y | PSACH | C779 | Ca 10 coordination and disulfide bond | Ca 10 coordination |
| D361Y/A/V | EDM1 | D789 | Ca 11 coordination | Ca 11 coordination |
| G366R | EDM1 | G794 | ? | |
| G368R | EDM1 | G796 | ? | |
| C371S/F | EDM1 | C799 | disulfide bond | disulfide bond |
| D376V | PSACH | D804 | Ca 12 and 13 coordination | Ca 12 and 13 coordination |
| D378Y | EDM1 | D806 | Ca 12 and 13 coordination | Ca 12 and 13 coordination |
| D385N | EDM1 | D813 | Ca 12 and 13 coordination | Ca 12 and 13 coordination |
| C387G | PSACH | C815 | Ca 13 coordination and disulfide bond | Ca 13 coordination |
| D399N | EDM1 | D827 | Ca 14 and 15 coordination | Ca 14 and 15 coordination |
| D401N | EDM1 | D829 | Ca 14 and 15 coordination | Ca 14 and 15 coordination |
| C407F/S | EDM1 | C835 | disulfide bond | disulfide bond |
| D408Y | EDM1 | D836 | Ca 14 and 15 coordination | Ca 14 and 15 coordination |
| D420A | EDM1 | D848 | Ca 16 coordination | Ca 16 coordination |
| G427E | PSACH | G855 | ? | |
| D437G | PSACH | D865 | Ca 18 and 19 coordination | Ca 18 and 19 coordination |
| D439N | EDM1 | D867 | Ca 18 and 19 coordination | Ca 18 and 19 coordination |
| G440R/E | PSACH | G868 | ? | |
| D446N | PSACH | D874 | Ca 18 and 19 coordination | Ca 18 and 19 coordination |
| P449T | PSACH | P877 | ? | |
| N453S | EDM1 | N881 | Ca 19 coordination | Ca 19 coordination |
| S454R | EDM1 | A883 | interaction with lectin | interaction with lectin |
| G465R/S | PSACH | G893 | ? | |
| C468Y | PSACH | C896 | disulfide bond | disulfide bond |
| D471G | PSACH | D899 | Ca 21 and 23 coordination | Ca 21 and 23 coordination |
| D472Y | PSACH | D900 | Ca 22 coordination | Ca 22 coordination |
| D473G/N/Y | EDM1/PSACH | D901 | Ca 23 and 24 coordination | Ca 23 and 24 coordination |
| D475N | PSACH | D903 | Ca 23 and 24 coordination | Ca 23 and 24 coordination |
| D479H/Y | EDM1/PSACH | D907 | Ca 22 and 23 coordination | Ca 22 and 23 coordination |
| D482G/H | PSACH | D910 | Ca 23 and 24 coordination | Ca 23 and 24 coordination |
| C484G | EDM1 | C912 | Ca 24 coordination and disulfide bond | Ca 24 coordination |
| N489K | EDM1 | N917 | Ca 24 coordination | Ca 24 coordination |
| Q492P | EDM1 | Q920 | ? | |
| C504S | PSACH | C932 | disulfide bond | disulfide bond |
| D507G | PSACH | D935 | Ca 26 coordination | Ca 26 coordination |
| D509A/G/E | PSACH | D937 | Ca 26 and 27 coordination | Ca 26 and 27 coordination |
| D511H | PSACH | D939 | Ca 26 and 27 coordination | Ca 26 and 27 coordination |
| D518G/N/H | PSACH | D946 | Ca 26 and 27 coordination | Ca 26 and 27 coordination |
| N523K | EDM1 | N951 | Ca 27 coordination | Ca 27 coordination |
| T527A | PSACH | S955 | Possible Ca2+ coordination | Possible Ca2+ coordination |
| Lectin | ||||
| T5291 | PSACH | T957 | interaction with wire | interaction with wire |
| N555K | EDM1 | N993 | Ca 30 coordination | Ca 30 coordination |
| E583K | PSACH | S1011 | interaction with wire | interaction with wire |
| T585R/M | PSACH/EDM1 | T1013 | interaction with wire | interaction with wire |
| H587R | PSACH | Y1015 | interaction with wire | interaction with wire |
| D605N | EDM1 | S1033 | interaction with wire | interaction with wire |
| S681C | EDM1 | A1109 | interaction with wire | interaction with wire |
| R718P/W | EDM1 | A1146 | interaction with wire | interaction with wire |
| G719D/S | PSACH | G1147 | interaction with wire | interaction with wire |
| Deletions or insertions | ||||
| DP277-283del | PSACH | NA702-708 | ? | spacing |
| ED341-342del | PSACH | KD769-770 | Ca 9 and 10 coordination | Ca 9 and 10 coordination |
| RG367-368del | EDM1 | EG795-796 | Ca 11 coordination | Ca 11 coordination |
| D372del | PSACH | S800 | ? | spacing |
| D373del | PSACH | V801 | ? | spacing |
| D374del | PSACH | D802 | Ca 12 coordination | Ca 12 coordination |
| N386del | EDM1 | N814 | ? | |
| PNSD391-394C | PSACH | YNTD819-822 | Ca 13 coordination | Ca 13 coordination |
| QKD395-397del | PSACH | QRD823-825 | Ca 14 coordination | Ca 14 coordination |
| E457del | PSACH | A885 | hairpin turn/structural | hairpin turn /structural |
| S459del | PSACH | H887 | hairpin turn/structural | hairpin turn /structural |
| D469insertD | EDM1 | D897 | Ca 20 and 21 coordination | Ca 20 and 21 coordination |
| D469del | PSACH | D897 | Ca 20 and 21 coordination | Ca 20 and 21 coordination |
| D469insertDD | PSACH | D897 | Ca 20 and 21 coordination | Ca 20 and 21 coordination |
| DD469-70delDD | PSACH | DP897-8 | Ca 20 and 21 coordination | Ca 20 and 21 coordination |
| D470del | PSACH | P898 | ? | spacing |
| D471del | PSACH | D899 | Ca 21 and 23 coordination | Ca 21 and 23 coordination |
| D472del | PSACH | D900 | Ca 22 coordination | Ca 22 coordination |
| D473del | PSACH | D901 | Ca 23 and 24 coordination | Ca 23 and 24 coordination |
| GDV501-3del | EDM1 | GDI929-31 | Ca 25 coordination | Ca 25 coordination |
| ADKV510-513del | PSACH | NDNI938-941 | Ca 26 and 27 coordination | Ca 26 and 27 coordination |
| VVDK513-516del | PSACH | IPDI941-944 | Ca 26 coordination | Ca 26 coordination |
| N742stop | EDM1 | R1170 | interaction with E3 | interaction with E3 |
Over 100 signature-domain mutations in TSP-5 (also known as cartilage oligomeric matrix protein or COMP) have been associated with the bone and joint diseases PSACH and EDM1 (Supplementary Table 2 online){Kennedy, 2005 #3585;Posey, 2004 #3579}. The mechanism by which these mutations cause disease is through the accumulation of unstable or misfolded protein intracellularly in chondrocytes{Dinser, 2002 #3587}. Of the disease-linked TSP-5 mutations, 81 are missense mutations that change residues at 62 different positions in the signature domain. Of the 62 positions, 53 are wire residues that are conserved between TSP-2 and -5 and all but nine are involved in coordination of Ca2+, disulfide formation, or globe-wire interactions in TSP-2 (Fig. 3 and Supplementary Table 2 online). Twenty-two additional disease-linked mutations result in insertions or deletions of residues in the wire and would disrupt its proper spacing. Thus, the disease-causing mutations in TSP-5 target features that are critical for the Ca2+-sensitive structure of the wire or the interactions between the wire and the globe.
The structure presented here provides perspective for examining the functions of TSPs. Until now, activities have been assigned to various parts of TSPs using antibody mapping and other techniques{Adams, 1995 #2328}. However it is now clear that TSPs cannot be considered a mosaic of independent domains, but instead have a convoluted structure stabilized by multiple interactions. Because Ca2+ clearly plays a dominant role in the formation of the final fold of the signature domain, fluctuations in Ca2+ concentration likely modify the function of TSPs by regulating the nature of the interactions mediated by the domain. It will be important to learn how TSPs change in structure and function as Ca2+ is depleted and identify compartments in which relevant changes in Ca2+ concentration occur. In short, the present structure offers both a rationale for the structural consequences of the numerous genetic changes in TSPs that are associated with disease and a foundation for understanding how TSPs normally function.
Methods
Expression and Purification of the human TSP-2 signature domain
Recombinant human TSP-2 signature domain protein (residues 551-1172 with ADP and ARGHHHHHH N- and C-terminal sequence tags) was expressed in conditioned insect cell media{Mosher, 2002 #3508}. The expression protocol was modified for incorporation of selenomethionine into the protein{McWhirter, 1999 #3572},{Bellizzi, 1999 #3573} as follows. High5 insect cells in SF-900 II SFM media were infected at a multiplicity of infection of 5. Twenty-four hours after infection, the cells were centrifuged and resuspended in SF-900 II SFM methionine- and cysteine-free media supplemented with dialyzed fetal calf serum (FBS) to 10% (v/v) and 0.15 g L−1 cysteine. After four hours of growth at 27°C, the cells were centrifuged and resuspended in SF-900 II SFM methionine- and cysteine-free media supplemented with 0.15 g L−1 cysteine, 10% FBS and 1 g L−1 selenomethionine, and grown for 48 hours before harvesting. Soluble TSP-2 signature domain was purified by nickel-chelate affinity chromatography and dialyzed into low-salt buffer (20 mM MOPS, 50 mM NaCl, 2 mM CaCl2). The dialysate was further purified by MonoQ ion exchange column. Pure protein was concentrated and dialyzed into 5 mM MOPS, 2 mM CaCl2, 100 mM sodium acetate, pH 7.5 for crystallization.
Crystallization of selenomethionine-incorporated TSP-2 signature domain
The TSP-2 signature domain was crystallized using the hanging drop vapor diffusion method at room temperature. 1 μL of protein was mixed with 1 μL of mother liquor (100 mM Tris-Cl pH 8.5-9.0, 200 mM sodium acetate, 30% polyethylene glycol 4000) and 100 mM glycine and equilibrated with mother liquor. Selenomethionine-incorporated protein crystals required streak seeding from native crystals. Prior to data collection, crystals were stabilized by transfer to a cryoprotectant solution of the above mother liquor conditions supplemented with 25% ethylene glycol and frozen directly in liquid nitrogen.
Data collection and structure solution
Data were collected at 100 K at the Advanced Photon Source (BioCARS beamline 14-IDB) using X-rays of energies 12662 eV, 12958 eV, and 12658 eV. The structure was solved at 2.6 Å resolution using a combination of multiple-wavelength anomalous dispersion (MAD) phasing and molecular replacement (Supplementary Table 3). MAD data were indexed and scaled using HKL2000{Otwinowski, 1997 #3593}. Selenium sites were found using SOLVE{Terwilliger, 1999 #3590} and refined using MLPHARE{, 1994 #3597}. Solvent flattening with DM{, 1994 #3597} resulted in poor quality experimental electron density. To aid in building, a model of TSP-1 that includes the lectin-like domain and several of its proximal aspartate repeats{Kvansakul, 2004 #3561} was manually placed into the electron density maps by fitting the sulfurs from the TSP-1 methionines to the selenium sites determined above. Refinement with REFMAC5{, 1994 #3597} produced interpretable 2Fo-Fc and Fo-Fc electron density maps. The model was improved by rounds of refinement with REFMAC5 and manual rebuilding to an Rfactor of 21.8 % (Rfree = 28.4 %, Supplementary Table 3). The unbiased MAD-phased electron density maps were used to prevent model bias throughout refinement. 76.7% of all residues fall in the most favored Ramachandran category, with 21.0% in the allowed category, 1.9% in the generously allowed category and 0.4% in the disallowed category.
Supplementary Table 3.
Data collection, phasing and refinement statistics
| Data collection | |||
| Space group | I222 | ||
| Cell dimensions | |||
| a, b, c (Å) | 93.44, | ||
| 121.59, | |||
| 155.33 | |||
| α β γ (º) | 90, 90, 90 | ||
|
Peak
|
Inflection
|
Remote
|
|
| Wavelength (Å) | 0.9792 | 0.9795 | 0.9568 |
| Resolution (Å) | 50-2.6 | 50-2.6 | 50-2.6 |
| Rsym or Rmerge (%) | 8.3 (27.5) | 8.2 (31.9) | 8.9 (29.6) |
| I/σI | 18.6 (2.8) | 17.6 (2.5) | 23.2 (3.3) |
| Completeness (%) | 93.8 (60.9) | 89.7 (35.3) | 96.2 (79.6) |
| Redundancy | 4.9 (3.2) | 4.8 (2.6) | 9.3 (6.2) |
| Refinement | |||
| Resolution (Å) | 20-2.6 | ||
| No. reflections | 23,531 | ||
| Rwork/Rfree (%) | 21.8/28.4 | ||
| No. atoms | 4939 | ||
| Protein/glycosylation | |||
| Ca++ ions | 30 | ||
| Water | 116 | ||
| B-factors | 68 | ||
| Protein/glycosylation | |||
| Ca++ ions | 62 | ||
| Water | 54 | ||
| R.m.s deviations | |||
| Bond lengths (Å) | 0.012 | ||
| Bond angles (º) | 1.15 | ||
Highest resolution shell (2.69-2.6 Å) is shown in parenthesis.
Coordinates
Model coordinates and structure factors have been deposited in the Protein Data Bank (1YO8 accession code).
Figure 3.

Disease-associated mutations or polymorphisms of TSPs mapped onto the signature domain of human TSP-2. Residues homologous to positions in TSP-5 that are sites where missense mutations are linked to PSACH or EDM1, or to the polymorphism in TSP-1 that is linked to coronary artery disease are colored yellow and shown in stick form. The wire module is shown in cartoon form with the remainder the signature domain shown as a surface representation to highlight the 62 positions of the missense mutations. Fifty-two map to the wire region and 10 map to surfaces on the lectin-module. Twenty-two additional non-missense mutations are not highlighted but also map to the wire module (Supplementary Fig. 2 online).
Acknowledgments
We thank Erhard Hohenester for communicating results prior to publication and the Advanced Photon Source beamline staff (BioCARS beamline 14-IDB) for assistance in data collection. This work was supported by an NIH grant to DFM (HC54462) and a grant from Shaw Foundation for Medical Research to JLK. CBC and DAB were supported by NIH training grants (HC07899 and GM08293).
Footnotes
Kvansakul, M., Adams, J. C. & Hohenester, E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. Embo Journal 23, 1223–1233 (2004).
References
- 1.Adams JC, Lawler J. The thrombospondins. Int J Biochem Cell B. 2004;36:961–8. doi: 10.1016/j.biocel.2004.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Christopherson KS, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005;120 :421–33. doi: 10.1016/j.cell.2004.12.020. [DOI] [PubMed] [Google Scholar]
- 3.Kyriakides TR, et al. Megakaryocytes require thrombospondin-2 for normal platelet formation and function. Blood. 2003;101 :3915–23. doi: 10.1182/blood.V101.10.3915. [DOI] [PubMed] [Google Scholar]
- 4.Kyriakides TR, Zhu YH, Yang ZT, Huynh G, Bornstein P. Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice. Am J Pathol. 2001;159:1255–1262. doi: 10.1016/S0002-9440(10)62512-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Adams JC, et al. Characterisation of Drosophila thrombospondin defines an early origin of pentameric thrombospondins. J Mol Biol. 2003;328 :479–94. doi: 10.1016/s0022-2836(03)00248-1. [DOI] [PubMed] [Google Scholar]
- 6.LaBell TL, Byers PH. Sequence and characterization of the complete human thrombospondin 2 cDNA: potential regulatory role for the 3' untranslated region. Genomics. 1993;17 :225–229. doi: 10.1006/geno.1993.1308. [DOI] [PubMed] [Google Scholar]
- 7.Topol EJ, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation. 2001;104:2641–2644. doi: 10.1161/hc4701.100910. [DOI] [PubMed] [Google Scholar]
- 8.Kennedy J, et al. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia - multiple epiphyseal dysplasia disease group. Hum Mutat. 2005;25:593–4. doi: 10.1002/humu.9342. [DOI] [PubMed] [Google Scholar]
- 9.Posey KL, Hayes E, Haynes R, Hecht JT. Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell B. 2004;36 :1005–12. doi: 10.1016/j.biocel.2004.01.011. [DOI] [PubMed] [Google Scholar]
- 10.Kvansakul M, Adams JC, Hohenester E. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats. EMBO J. 2004;23 :1223–1233. doi: 10.1038/sj.emboj.7600166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wouters MA, et al. Evolution of distinct EGF domains with specific functions. Protein Sci. 2005;14:1091–1103. doi: 10.1110/ps.041207005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Boswell, E.J., Kurniawan, N.D., Downing, A.K. In Handbook of Metalloproteins Vol. 3. (ed. Messerschmidt, A., Bode, W., Cygler, M.) 553–570 (Wiley, Chichester; 2004).
- 13.Misenheimer TM, Hannah BL, Annis DS, Mosher DF. Interactions among the three structural motifs of the C-terminal region of human thrombospondin-2. Biochemistry. 2003;42 :5125–32. doi: 10.1021/bi026983p. [DOI] [PubMed] [Google Scholar]
- 14.Misenheimer TM, Hahr AJ, Harms AC, Annis DS, Mosher DF. Disulfide connectivity of recombinant C-terminal region of human thrombospondin 2. J Biol Chem. 2001;276 :45882–45887. doi: 10.1074/jbc.M104218200. [DOI] [PubMed] [Google Scholar]
- 15.Lawler J, Chao FC, Cohen CM. Evidence for calcium-sensitive structure in platelet thrombospondin: Isolation and partial characterization of thrombospondin in the presence of calcium. J Biol Chem. 1982;257 :12257–12265. [PubMed] [Google Scholar]
- 16.Lawler J, Derick LH, Connolly JE, Chen JH, Chao FC. The structure of human platelet thrombospondin. J Biol Chem. 1985;260 :3762–3772. [PubMed] [Google Scholar]
- 17.Chen H, Aeschlimann D, Nowlen J, Mosher D. Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3. FEBS Lett. 1996;387 :36–41. doi: 10.1016/0014-5793(96)00460-7. [DOI] [PubMed] [Google Scholar]
- 18.Lawler J, Hynes RO. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. Blood. 1989;74 :2022–2027. [PubMed] [Google Scholar]
- 19.Chen H, Sottile J, O'Rourke KM, Dixit VM, Mosher DF. Properties of recombinant mouse thrombospondin 2 expressed in Spodoptera cells. J Biol Chem. 1994;269:32226–32232. [PubMed] [Google Scholar]
- 20.Gao AG, Frazier WA. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins. J Biol Chem. 1994;269:29650–29657. [PubMed] [Google Scholar]
- 21.Hannah BL, Misenheimer TM, Pranghofer MM, Mosher DF. A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding. J Biol Chem. 2004;279:51915–22. doi: 10.1074/jbc.M409632200. [DOI] [PubMed] [Google Scholar]
- 22.Dinser R, et al. Pseudoachondroplasia is caused through both intra-and extracellular pathogenic pathways. J Clin Invest. 2002;110 :505–513. doi: 10.1172/JCI14386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Adams, J.C., Tucker, R.P. & Lawler, J. In The thrombospondin gene family. (R.G. Landes Company, Austin; 1995).
- 24.Mosher DF, Huwiler KG, Misenheimer TM, Annis DS. Expression of recombinant matrix components using baculoviruses. Method Cell Biol. 2002;69:69–81. doi: 10.1016/s0091-679x(02)69008-9. [DOI] [PubMed] [Google Scholar]
- 25.McWhirter SM, et al. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. P Natl Acad Sci USA. 1999;96:8408–13. doi: 10.1073/pnas.96.15.8408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Bellizzi JJ, Widom J, Kemp CW, Clardy J. Producing selenomethionine-labeled proteins with a baculovirus expression vector system. Struct Fold Des. 1999;7:R263–7. doi: 10.1016/s0969-2126(00)80020-9. [DOI] [PubMed] [Google Scholar]
- 27.Otwinowski, Z., Minor, W. in Methods in Enzymology. (ed. Carter, C.W., Sweet, R.M.) 307–326 (Academic Press, New York; 1997).
- 28.Terwilliger TC, Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr D. 1999;55 ( Pt 4):849–61. doi: 10.1107/S0907444999000839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.The CCP4 suite: programs for protein crystallography. . Acta Crystallogr D. 1994;50:760–3. doi: 10.1107/S0907444994003112. [DOI] [PubMed] [Google Scholar]
